Publications by authors named "K Peerlinck"

Claim this Profile
G
Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism.
Christine Van Laer, Marthe Vanrenterghem, Marc Jacquemin, Andreas Verstraete, Sarissa Baert, Kathelijne Peerlinck

J Thromb Haemost· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional assessment of genetic variants in thrombomodulin detected in patients with bleeding and thrombosis.
Christine Van Laer, Renaud Lavend'homme, Sarissa Baert, Koenraad De Wispelaere, Chantal Thys, Kathelijne Peerlinck

Blood· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1.
Brian O'Mahony, Amy L Dunn, Andrew D Leavitt, Flora Peyvandi, Margareth C Ozelo, Kathelijne Peerlinck

J Thromb Haemost· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab for acquired haemophilia A: A case series.
Matthias M Engelen, Johan Vandesande, Johan De Bent, Christine Van Laer, Veerle Labarque, Kathelijne Peerlinck

Haemophilia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
Steven W Pipe, Frank W G Leebeek, Michael Recht, Nigel S Key, Giancarlo Castaman, Kathelijne Peerlinck

N Engl J Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis